Is IPIX or ORCC a better dividend investment in 2026?

IPIX currently yields 285714.29% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: IPIX offers higher current income.

What is the dividend yield difference between IPIX and ORCC?

IPIX has a forward dividend yield of 285714.29% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 285704.50 percentage points.

Home › Compare › IPIX vs ORCC

IPIX vs ORCC: Dividend Comparison 2026

IPIX yields 285714.29% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IPIX wins by $1.734986541242196e+31M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IPIX

● Live price

285714.29%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.734986541242196e+31M

Annual income

$17,337,928,197,276,910,000,000,000,000,000,000,000.00

Full IPIX calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — IPIX vs ORCC

📍 IPIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IPIX	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IPIX + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IPIX pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IPIX

Annual income on $10K today (after 15% tax)

$24,285,714.29/yr

After 10yr DRIP, annual income (after tax)

$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, IPIX beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IPIX + ORCC for your $10,000?

IPIX: 50%ORCC: 50%

100% ORCC50/50100% IPIX

Portfolio after 10yr

$8.67493270621098e+30M

Annual income

$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr

Blended yield

99.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

IPIX

No analyst data

Altman Z

-28.5

Piotroski

2/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IPIX buys

ORCC buys

No recent congressional trades found for IPIX or ORCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIPIXORCC

Forward yield	285714.29% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$1.734986541242196e+31M	$21.4K ✓
Annual income after 10y	$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓	$1.04
Total dividends collected	$1.734908400352195e+31M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: IPIX vs ORCC ($10,000, DRIP)

Year	IPIX Portfolio	IPIX Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$28,582,129	$28,571,428.57	$11,190	$489.61	+$28.57M → IPIX
2	$76,351,353,429	$76,320,770,551.21	$12,229	$256.01	+$76351.34M → IPIX
3	$190,619,493,207,524	$190,537,797,259,355.30	$13,216	$130.74	+$190619493.19M → IPIX
4	$444,781,927,427,195,200	$444,577,964,569,463,100.00	$14,207	$66.02	+$444781927427.18M → IPIX
5	$969,967,353,346,567,200,000	$969,491,436,684,220,000,000.00	$15,234	$33.17	+$969967353346567.13M → IPIX
6	$1,976,961,629,315,093,000,000,000	$1,975,923,764,247,012,300,000,000.00	$16,317	$16.62	+$1976961629315092992.00M → IPIX
7	$3,765,923,944,594,039,000,000,000,000	$3,763,808,595,650,671,000,000,000,000.00	$17,468	$8.32	+$3.765923944594039e+21M → IPIX
8	$6,704,681,437,057,684,000,000,000,000,000	$6,700,651,898,436,968,000,000,000,000,000.00	$18,695	$4.16	+$6.704681437057683e+24M → IPIX
9	$11,156,275,836,497,016,000,000,000,000,000,000	$11,149,101,827,359,364,000,000,000,000,000,000.00	$20,006	$2.08	+$1.1156275836497015e+28M → IPIX
10	$17,349,865,412,421,960,000,000,000,000,000,000,000	$17,337,928,197,276,910,000,000,000,000,000,000,000.00	$21,407	$1.04	+$1.734986541242196e+31M → IPIX

IPIX vs ORCC: Complete Analysis 2026

IPIX — Stock

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company is also developing Kevetrin, an anti-cancer compound for treating ovarian cancer. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.

Full IPIX Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this IPIX vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IPIX vs SCHD IPIX vs JEPI IPIX vs O IPIX vs KO IPIX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.